Carbonic anhydrase IX expression, a novel surrogate marker of tumor hypoxia, is associated with a poor prognosis in non-small-cell lung cancer

Journal of Clinical Oncology

Volumn 21, Issue 3, 2003, Pages 473-482

  Swinson, Daniel E B ^a   Jones, J Louise ^a   Richardson, Donna ^a   Wykoff, Charles ^a   Turley, Helen ^a   Pastorek, Jaromir ^a   Taub, Nick ^a   Harris, Adrian L ^a   O'Byrne, Kenneth J ^a  

^a JOHN RADCLIFFE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CARBONATE DEHYDRATASE IX; CA9 PROTEIN, HUMAN; CARBONATE DEHYDRATASE; ISOENZYME; TUMOR ANTIGEN; TUMOR MARKER; TUMOR PROTEIN;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; CANCER STAGING; CELL HYPOXIA; CELLULAR DISTRIBUTION; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; OXYGEN TENSION; PHENOTYPE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN LOCALIZATION; THROMBOCYTE COUNT; TUMOR NECROSIS; BIOSYNTHESIS; CELL CULTURE; DISEASE COURSE; GENETICS; LUNG TUMOR; MIDDLE AGED; NECROSIS; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; SURVIVAL; WESTERN BLOTTING;

ADULT; AGED; ANTIGENS, NEOPLASM; BLOTTING, WESTERN; CARBONIC ANHYDRASES; CARCINOMA, NON-SMALL-CELL LUNG; CELL HYPOXIA; DISEASE PROGRESSION; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; ISOENZYMES; LUNG NEOPLASMS; MALE; MIDDLE AGED; NECROSIS; NEOPLASM PROTEINS; NEOVASCULARIZATION, PATHOLOGIC; PHENOTYPE; PROGNOSIS; SURVIVAL; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL;

EID: 0037315252     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2003.11.132     Document Type: Article

References (40)

1. Choi N, Baumann M, Flentjie M, et al: Predictive factors in radiotherapy for non-small-cell lung cancer: Present status. Lung Cancer 31:43-56, 2001
2. Hockel M, Schlenger K, Aral B, et al: Association between tumor hypoxia and malignant progression in advanced cancer of the uterine cervix. Cancer Res 56:4509-4515, 1996
3. Stadler P, Becker A, Feldmann HJ, et al: Influence of the hypoxic subvolume on the survival of patients with head and neck cancer. Int J Radiat Oncol Biol Phys 44:749-754, 1999
4. Wykoff CC, Beasley N, Watson PH, et al: Expression of the hypoxia-inducible and tumor-associated carbonic anhydrases in ductal carcinoma in situ of the breast. Am J Pathol 158:1011-1019, 2001
5. Beasley NJ, Wykoff CC, Watson PH, et al: Carbonic anhydrase IX, an endogenous hypoxia marker, expression in head and neck squamous cell carcinoma and its relationship to hypoxia, necrosis, and microvessel density. Cancer Res 61:5262-5267, 2001
6. Chia SK, Wykoff CC, Watson PH, et al: Prognostic significance of a novel hypoxia-regulated marker, carbonic anhydrase IX, in invasive breast carcinoma. J Clin Oncol 19:3660-3668, 2001
7. Raleigh JA, Chou SC, Arteel GE, et al: Comparisons among pimonidazole binding, oxygen electrode measurements, and radiation response in C3H mouse tumors. Radiat Res 151:580-589, 1999
8. Haustermans K, Hofland I, Van de Pavert L, et al: Diffusion-limited hypoxia estimated by vascular image analysis: Comparison with pimonidazole staining in human tumors. Radiother Oncol 55:325-333, 2000
9. Varia MA, Calkins-Adams DP, Rinker LH, et al: Pimonidazole: A novel hypoxia marker for complementary study of tumor hypoxia and cell proliferation in cervical carcinoma. Gynecol Oncol 71:270-277, 1998
10. Wykoff CC, Beasley NJ, Watson PH, et al: Hypoxia-inducible expression of tumor-associated carbonic anhydrases. Cancer Res 60:7075-7083, 2000
11. Loncaster JA, Harris AL, Davidson SE, et al: Carbonic anhydrase (CA IX) expression, a potential new intrinsic marker of hypoxia: Correlations with tumor oxygen measurements and prognosis in locally advanced carcinoma of the cervix. Cancer Res 61:6394-6399, 2001
12. Liao SY, Stanbridge EJ: Expression of MN/CA9 protein in Papanicolaou smears containing atypical glandular cells of undetermined significance is a diagnostic biomarker of cervical dysplasia and neoplasia. Cancer 88:1108-1121, 2000
13. Vermylen P, Roufosse C, Burny A, et al: Carbonic anhydrase IX antigen differentiates between preneoplastic malignant lesions in non-small-cell lung carcinoma. Eur Respir J 14:806-811, 1999
14. Liao SY, Aurelio ON, Jan K, et al: Identification of the MN/CA9 protein as a reliable diagnostic biomarker of clear cell carcinoma of the kidney. Cancer Res 57:2827-2831, 1997
15. Tsuzuki Y, Fukumura D, Oosthuyse B, et al: Vascular endothelial growth factor (VEGF) modulation by targeting hypoxia-inducible factor-1 alpha -> hypoxia response element -> VEGF cascade differentially regulates vascular response and growth rate in tumors. Cancer Res 60:6248-6252, 2000
16. Giatromanolaki A, Koukourakis M, Sivridis E, et al: Relation of hypoxia inducible factor 1 alpha and 2 alpha in operable non-small cell lung cancer to angiogenic/molecular profile of tumours and survival. Br J Cancer 85:881-890, 2001
17. Rubins JB, Ewing SL, Leroy S, et al: Temporal trends in survival after surgical resection of localized non-small cell lung cancer. Lung Cancer 28:21-27, 2000
18. Pastorekova S, Zavadova Z, Kostal M, et al: A novel quasi-viral agent, MaTu, is a two-component system. Virology 187:620-626, 1992
19. Saarnio J, Parkkila S, Parkkila AK, et al: Immunohistochemical study of colorectal tumors for expression of a novel transmembrane carbonic anhydrase, MN/CA IX, with potential value as a marker of cell proliferation. Am J Pathol 153:279-285, 1998
20. Swinson DE, Jones JL, Richardson D, et al: Tumour necrosis is an independent prognostic marker in non-small cell lung cancer: Correlation with biological variables. Lung Cancer 37:235-240, 2002
21. O'Byrne KJ, Koukourakis MI, Giatromanolaki A, et al: Vascular endothelial growth factor, platelet-derived endothelial cell growth factor and angiogenesis in non-small-cell lung cancer. Br J Cancer 82:1427-1432, 2000
22. Cox G, Jones JL, Andi A, et al: A biological staging model for operable non-small cell lung cancer. Thorax 56:561-566, 2001
23. Ishizaki M, Zhu G, Haseba T, et al: Expression of collagen I, smooth muscle alpha-actin, and vimentin during the healing of alkali-burned and lacerated corneas. Invest Ophthalmol Vis Sci 34:3320-3328, 1993
24. Thomlinson RH, Gray LH: The histological structure of some human lung cancers and the possible implications for radiotherapy. Br J Cancer 9:539-549, 1955
25. Underwood JCE, Hunter J: General and systematic pathology. Churchill Livingstone, New York, 1994, p 343
26. Sekido Y, Bader S, Latif F, et al: Molecular analysis of the von Hippel-Lindau disease tumor suppressor gene in human lung cancer cell lines. Oncogene 9:1599-1604, 1994
27. Zhong H, Chiles K, Feldser D, et al: Modulation of hypoxia-inducible factor 1 alpha expression by the epidermal growth factor/phosphatidylinositol 3-kinase/PTEN/AKT/FRAP pathway in human prostate cancer cells: Implications for tumor angiogenesis and therapeutics. Cancer Res 60:1541-1545, 2000
28. Clarke K, Smith K, Gullick WJ, et al: Mutant epidermal growth factor receptor enhances induction of vascular endothelial growth factor by hypoxia and insulin-like growth factor-1 via a PI3 kinase dependent pathway. Br J Cancer 84:1322-1329, 2001
29. Ausprunk DH, Folkman J: Vascular injury in transplanted tissues: Fine structural changes in tumor, adult, and embryonic blood vessels. Virchows Arch B Cell Pathol 31-44, 1976
30. Alberts A, Watson JD, Roberts K, et al: Molecular Biology of the Cell (ed 3). London, UK, Garland Publishing, 1989, pp 433-451
31. Zavada J, Zavadova Z, Pastorekova S, et al: Expression of MaTu-MN protein in human tumor cultures and in clinical specimens. Int J Cancer 54:268-274, 1993
32. Karhumaa P, Parkkila S, Waheed A, et al: Nuclear NonO/p54(nrb) protein is a nonclassical carbonic anhydrase. J Biol Chem 275:16044-16049, 2000
33. Hofmann HS, Taege C, Lautenschlager C, et al: Microscopic (R1) and macroscopic (R2) residual disease in patients with resected non-small cell lung cancer. Eur J Cardiothorac Surg 21:606-610, 2002
34. Deinemann H, Trainer C, Hoffmann H, et al: Incomplete resections in bronchial carcinoma: Morbidity and prognosis. Chirurg 68:1014-1019, 1997
35. Ghiribelli C, Voltolini L, Paladini P, et al: Treatment and survival after lung resection for non-small cell lung cancer in patients with microscopic residual disease at the bronchial stump. Eur J Cardiothorac Surg 16:555-559, 1999
36. Liewald F, Hatz RA, Dienemann H, et al: Importance of microscopic residual disease at the bronchial margin after resection for non-small cell carcinoma of the lung. J Thorac Cardiovasc Surg 104:408-412, 1992
37. Parkkila S, Rajaniemi H, Parkkila AK, et al: Carbonic anhydrase inhibitor suppresses invasion of renal cancer cells in vitro. Proc Natl Acad Sci USA 5:2220-2224, 2000
38. Supuran CT, Briganti F, Tilli S, et al: Carbonic anhydrase inhibitors: Sulfonamides as antitumor agents? Bioorg Med Chem 9:703-714, 2001
39. Teicher BA, Liu SD, Liu JT, et al: A carbonic anhydrase inhibitor as a potential modulator of cancer therapies. Anticancer Res 13:1549-1556, 1993
40. Nakagawa Y, Uemura H, Shimizu K, et al: The role of MN/CA IX antigen in carcinogenesis and metastasis of renal cell carcinoma. Hinyokika Kiyo 47:809-814, 2001